What is the recommended duration of use for Chlorzoxazone and Tizanidine (muscle relaxants) in treating muscle spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Use for Chlorzoxazone and Tizanidine

Chlorzoxazone should be used for no more than 2-3 weeks, while tizanidine can be used for longer periods with appropriate monitoring, but requires tapering if used long-term to avoid withdrawal effects.

Chlorzoxazone Duration Guidelines

Chlorzoxazone is a centrally-acting muscle relaxant that works primarily at the spinal cord level to inhibit multisynaptic reflex arcs involved in muscle spasm 1. Regarding duration of use:

  • Clinical evidence supports only short-term use (2 weeks or less) for acute muscle spasms 2
  • The medication has a rapid onset of action, with detectable blood levels within 30 minutes and peak levels reached in 1-2 hours 1
  • There is insufficient evidence supporting long-term use beyond 2-3 weeks
  • The drug is rapidly metabolized and excreted in the urine, primarily in conjugated form as glucuronide 1

Clinical Considerations for Chlorzoxazone:

  • Most appropriate for acute paravertebral muscle spasm
  • Limited evidence for chronic use
  • Should be used as part of a comprehensive approach including physical therapy and other non-pharmacological interventions

Tizanidine Duration Guidelines

Tizanidine is an α2-adrenergic receptor agonist that acts as a centrally acting spasmolytic agent 2. Regarding duration:

  • For acute low back pain, tizanidine has been studied in trials lasting 2 weeks or less (with one exception of a 3-week trial) 2
  • For chronic conditions like spasticity from multiple sclerosis or spinal cord injury, longer-term use has been documented 3
  • A single dose reduces muscle tone for several hours, with peak effect at 1-2 hours and dissipation between 3-6 hours 4
  • Important safety consideration: If used long-term, tizanidine should be tapered slowly rather than stopped abruptly due to risk of withdrawal symptoms including rebound tachycardia, hypertension, and hypertonia 2

Dosing and Administration for Tizanidine:

  • Initial dosing: Start with 4mg doses (single doses less than 8mg have not been demonstrated effective in controlled studies, but lower doses reduce adverse events) 4
  • Gradually increase by 2-4mg steps to optimal effect 4
  • Can be repeated at 6-8 hour intervals, maximum three doses in 24 hours 4
  • Total daily dose should not exceed 36mg 4
  • Experience with daily doses exceeding 24mg is limited 4

Comparative Efficacy and Safety

  • Both medications are effective for acute muscle spasm, but tizanidine has more evidence for various indications including spasticity and chronic pain conditions 3
  • Tizanidine has shown quick pain relief (initial relief by day 2 of treatment, complete relief after 4 days) in back pain with muscle spasm 5
  • Skeletal muscle relaxants including both medications are associated with higher rates of total adverse events (RR 1.50) and central nervous system adverse events (RR 2.04) compared to placebo 2

Common Pitfalls and Precautions

  1. Abrupt discontinuation risk with tizanidine: Long-term use requires tapering to avoid withdrawal symptoms 2

  2. Drug interactions:

    • Tizanidine clearance is significantly reduced with CYP1A2 inhibitors (ciprofloxacin, fluvoxamine) 2
    • Significant hypotension, bradycardia, and sedation can occur when tizanidine is given with other CYP1A2 inhibitors 2
  3. Special populations:

    • Tizanidine should be avoided in patients with hepatic or renal dysfunction and in elderly patients due to significant sedative and hypotensive effects 2
  4. Sedation concerns:

    • Both medications can cause sedation, which may be problematic for patients who need to remain alert
    • Increased risk when combined with other CNS depressants 2

In summary, chlorzoxazone is best limited to short-term use (≤2 weeks) for acute conditions, while tizanidine may be used for both short-term and longer-term management with appropriate monitoring and gradual tapering when discontinuing after extended use.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Update on tizanidine for muscle spasticity and emerging indications.

Expert opinion on pharmacotherapy, 2008

Research

[Effects of back pain treatment with tizanidine].

Ortopedia, traumatologia, rehabilitacja, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.